Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

H. Blacklock · SciRah

Researcher profile · Semantic Scholar

H. Blacklock

Share profile

H. Blacklock — researcher profile on SciRah

h-index: 30
Works: 106
Citations: 5,158

Most-cited papers

Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group.
J. Berenson, A. Lichtenstein, L. Porter, M. Dimopoulos +13 more
1996New England Journal of Medicine1,077 citations
Semantic Scholar
Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.
J. Berenson, A. Lichtenstein, L. Porter, M. Dimopoulos +13 more
1998Journal of Clinical Oncology675 citations
Semantic Scholar
Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients.
H. Prentice, G. Janossy, L. Price-Jones, L. K. Trejdosiewicz +10 more
1984The Lancet348 citations
Semantic Scholar
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.
M. Dimopoulos, D. Siegel, S. Lonial, J. Qi +15 more
2013The Lancet Oncology234 citations
Semantic Scholar
Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial.
M. Mateos, H. Blacklock, F. Schjesvold, A. Oriol +22 more
2019The Lancet Haematology220 citations Open access
Semantic Scholar
Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci.
P. Griffiths, P. Stirk, M. Ganczakowski, D. Panjwani +3 more
1984The Lancet218 citations
Semantic Scholar
Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow transplantation for acute leukaemia.
H. Prentice, G. Janossy, D. Skeggs, H. Blacklock +3 more
1982The Lancet211 citations
Semantic Scholar
Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients.
I. Hann, H. Prentice, R. Corringham, H. Blacklock +8 more
1982The Lancet144 citations
Semantic Scholar
Acyclovir prophylaxis against herpes virus infections in severely immunocompromised patients: randomised double blind trial.
Ian Hann, H. Prentice, H. Blacklock, M. Ross +6 more
1983British medical journal135 citations Open access
Semantic Scholar
A technique for rapid isolation of bone marrow mononuclear cells using Ficoll‐Metrizoate and the IBM 2991 blood cell processor
M. Gilmore, H. Prentice, H. Blacklock, David D. F. Ma +2 more
1982British Journal of Haematology121 citations
Semantic Scholar
The effect of total body irradiation and bone marrow transplantation during childhood and adolescence on growth and endocrine function
A. Leiper, R. Stanhope, T. Lau, D. Grant +3 more
1987British Journal of Haematology117 citations
Semantic Scholar
Use of modified subcutaneous right-atrial catheter for venous access in leukaemic patients.
H. Blacklock, Roger S. Hill, A. G. Clarke, M. Pillai +2 more
1980The Lancet102 citations
Semantic Scholar
Plasma exchange in Goodpasture's syndrome.
I. Simpson, Peter B. Doak, Laurie C. Williams, H. Blacklock +4 more
1982American Journal of Nephrology96 citations
Semantic Scholar
ABO-incompatible bone-marrow transplantation: removal of red blood cells from donor marrow avoiding recipient antibody depletion.
H. Blacklock, H. Prentice, J. Evans, C. Knight +4 more
1982The Lancet74 citations
Semantic Scholar
THERAPEUTIC SELECTIVITY OF AND PREDICTION OF RESPONSE TO 2'-DEOXYCOFORMYCIN IN ACUTE LEUKAEMIA
H. Prentice, N. Lee, H. Blacklock, J. F. Smyth +4 more
198174 citations
Semantic Scholar
Bone-marrow transplantation has a limited role in prolonging second marrow remission in childhood lymphoblastic leukaemia.
J. Chessells, Alison Leiper, P. Plowman, R. Levinsky +4 more
1986The Lancet67 citations
Semantic Scholar
T cell regeneration after allogeneic bone marrow transplantation.
M. Favrot, G. Janossy, N. Tidman, H. Blacklock +6 more
1983Clinical and Experimental Immunology61 citations
Semantic Scholar
Surface antigenic determinants on human pluripotent and unipotent hematopoietic progenitor cells.
M. Bodger, C. Izaguirre, H. Blacklock, A. Hoffbrand
1983Blood59 citations Open access
Semantic Scholar
Four different mutations in codon 28 of alpha spectrin are associated with structurally and functionally abnormal spectrin alpha I/74 in hereditary elliptocytosis.
T. Coetzer, K. Sahr, J. Prchal, H. Blacklock +5 more
1991Journal of Clinical Investigation58 citations Open access
Semantic Scholar
Treatment of cyclophosphamide-induced cystitis with prostaglandin E2.
J. Mohiuddin, H. Prentice, S. Schey, H. Blacklock +1 more
1984Annals of Internal Medicine58 citations
Semantic Scholar
A and B blood group antigen expression on mixed colony cells and erythroid precursors: relevance for human allogeneic bone marrow transplantation
H. Blacklock, F. Katz, Rita Michalevicz, G. Hazlehurst +3 more
1984British Journal of Haematology54 citations
Semantic Scholar
ELIMINATION OF T‐LYMPHOCYTES FROM HUMAN BONE MARROW WITH MONOCLONAL T‐ANTIBODIES AND CYTOLYTIC COMPLEMENT
S. Granger, G. Janossy, G. Francis, H. Blacklock +2 more
1982British Journal of Haematology52 citations
Semantic Scholar
Vantage 088: Vorinostat in Combination with Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma: Results of a Global, Randomized Phase 3 Trial
M. Dimopoulos, S. Jagannath, S. Yoon, D. Siegel +15 more
201148 citations
Semantic Scholar
Specific hyperimmune globulin for cytomegalovirus pneumonitis.
H. Blacklock, Paul D. Griffiths, P. Stirk, H. Prentice
1985The Lancet48 citations
Semantic Scholar
T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrow.
G. Janossy, H. Prentice, J. Grob, K. Ivory +6 more
1986Clinical and Experimental Immunology44 citations
Semantic Scholar
Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry
K. Bergin, E. Moore, Z. Mcquilten, E. Wood +12 more
2016BMC Medical Research Methodology37 citations Open access
Semantic Scholar
Improved survival from acute lymphoblastic leukemia in adolescents and adults
H. Blacklock, John R. D. Matthews, John G. Buchanan, P. Ockelford +1 more
1981Cancer37 citations Open access
Semantic Scholar
Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy.
A. Thomas, J. Patterson, H. Prentice, Malcolm K. Brenner +5 more
1987Bone Marrow Transplantation35 citations
Semantic Scholar
A Technique for the Concentration of Nucleated Bone Marrow Cells for in vitro Manipulation or Cryopreservation Using the IBM 2991 Blood Cell Processor
M. Gilmore, H. Prentice, Robert Corringham, H. Blacklock +1 more
1983Vox Sanguinis31 citations
Semantic Scholar
Renal Impairment at Diagnosis in Myeloma: Patient Characteristics, Treatment, and Impact on Outcomes. Results From the Australia and New Zealand Myeloma and Related Diseases Registry.
P. Ho, E. Moore, Z. Mcquilten, C. Wellard +13 more
2019Clinical Lymphoma, Myeloma & Leukemia30 citations
Semantic Scholar
Salivary amylase and pancreatic enzymes in serum after total body irradiation.
D. Junglee, A. Katrak, J. Mohiuddin, H. Blacklock +2 more
1986Clinical Chemistry30 citations
Semantic Scholar
The pharmacokinetics of ketoconazole in severely immunocompromised patients.
I. Hann, H. Prentice, M. Keaney, Robert Corringham +4 more
1982Journal of Antimicrobial Chemotherapy29 citations
Semantic Scholar
Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes
Emma K Zadow, D. W. Wundersitz, D. Hughes, M. Adams +6 more
2020Seminars in Thrombosis and Hemostasis27 citations Open access
Semantic Scholar
Upfront lower dose lenalidomide is less toxic and does not compromise efficacy for vulnerable patients with relapsed refractory multiple myeloma: final analysis of the phase II RevLite study
H. Quach, L. Fernyhough, R. Henderson, G. Corbett +14 more
2017British Journal of Haematology26 citations Open access
Semantic Scholar
Elimination of T cells from human peripheral blood and bone marrow using a cocktail of three anti‐T cell immunotoxins
Fay Katz, G. Janossy, A. Cumber, W. Ross +3 more
1987British Journal of Haematology26 citations
Semantic Scholar
Real-World Outcome for Newly Diagnosed Patients with Functional High-Risk Myeloma - a Myeloma and Related Diseases Registry Analysis
A. Spencer, P. Mollee, H. Blacklock, S. Harrison +10 more
2019Blood25 citations Open access
Semantic Scholar
Primary prophylaxis with granulocyte colony-stimulating factor (GCSF) reduces the incidence of febrile neutropenia in patients with non-Hodgkin lymphoma (NHL) receiving CHOP chemotherapy treatment without adversely affecting their quality of life: cost–benefit and quality of life analysis
Sophie Lee, A. Knox, I. Zeng, C. Coomarasamy +2 more
2013Supportive Care in Cancer25 citations
Semantic Scholar
Predictors of early mortality in multiple myeloma: Results from the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)
Z. McQuilten, C. Wellard, E. Moore, B. Augustson +11 more
2022British Journal of Haematology24 citations Open access
Semantic Scholar
A phase 3 randomized study of pembrolizumab (Pembro) plus pomalidomide (Pom) and dexamethasone (Dex) for relapsed/refractory multiple myeloma (RRMM): KEYNOTE-183.
M. Mateos, H. Blacklock, F. Schjesvold, A. O. Rocafiguera +16 more
201824 citations
Semantic Scholar
Allogeneic bone marrow transplantation in a patient with acute myeloid leukemia secondary to Hodgkin's disease
T. de Witte, H. Blacklock, H. Prentice, B. D. de Pauw +1 more
1984Cancer23 citations Open access
Semantic Scholar
The Myeloma Landscape in Australia and New Zealand: The First 8 Years of the Myeloma and Related Diseases Registry (MRDR).
K. Bergin, C. Wellard, E. Moore, Z. Mcquilten +9 more
2021Clinical Lymphoma, Myeloma & Leukemia22 citations
Semantic Scholar
PROTHROMBINEX(®)-VF (PTX-VF) usage for reversal of coagulopathy: prospective evaluation of thrombogenic risk.
Louise Bobbitt, E. Merriman, J. Raynes, R. Henderson +2 more
2011Thrombosis Research19 citations
Semantic Scholar
Serum Ferritin in Patients with Hereditary Spherocytosis
H. Blacklock, M. Meerkin
1981British Journal of Haematology19 citations
Semantic Scholar
Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR)
K. Bergin, C. Wellard, B. Augustson, R. Cooke +11 more
2021Bone Marrow Transplantation18 citations
Semantic Scholar
Successful Treatment of Cytomegalovirus Pneumonitis After Allogeneic Bone Marrow Transplantation Using High Titre CMV Immunoglobulin (Cytotect)
H. Blacklock, P. Griffiths, P. Stirk, H. Prentice
198517 citations
Semantic Scholar
Treatment of cytophagic panniculitis with cyclosporin A.
G. Royle, H. Blacklock, Mary I. Miller
1992American Journal of Medicine16 citations
Semantic Scholar
The critical role of histology in distinguishing sarcoidosis from common variable immunodeficiency disorder (CVID) in a patient with hypogammaglobulinemia
R. Ameratunga, Y. Ahn, Dominic Tse, S. Woon +3 more
2019Allergy, Asthma & Clinical Immunology13 citations Open access
Semantic Scholar
Outcomes of patients with myelofibrosis treated with compassionate use pacritinib: a sponsor independent international study
J. Mascarenhas, E. Virtgaym, Marina Stal, H. Blacklock +7 more
2018Annals of Hematology13 citations Open access
Semantic Scholar
The outcome of clinical parameters in adults with severe Type I Gaucher disease using very low dose enzyme replacement therapy.
Callum Wilson, R. Spearing, L. Teague, P. Robertson +1 more
2007Molecular Genetics and Metabolism13 citations
Semantic Scholar
Maternal and perinatal predictors of newborn iron status.
Susan Morton, Rajneeta Saraf, D. Bandara, K. Bartholomew +7 more
2014The New Zealand medical journal12 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Prentice×11
Invite
H. Prentice — researcher profile on SciRah
A. Spencer×8
Invite
A. Spencer — researcher profile on SciRah
G. Janossy×7
Invite
G. Janossy — researcher profile on SciRah
H. Quach×7
Invite
H. Quach — researcher profile on SciRah

×6

Invite

H. Prentice — researcher profile on SciRah

Invite

E. Moore — researcher profile on SciRah

Invite

P. Mollee — researcher profile on SciRah

A. Hoffbrand×5

Invite

A. Hoffbrand — researcher profile on SciRah

Invite

K. Bergin — researcher profile on SciRah

Z. Mcquilten×5

Invite

Z. Mcquilten — researcher profile on SciRah

Invite

E. Wood — researcher profile on SciRah

B. Augustson×5

Invite

B. Augustson — researcher profile on SciRah